About This Formulation
MOTS-C is a mitochondrial-derived peptide that has been investigated for its activity within metabolic and cellular signaling pathways.
Human clinical evidence remains limited, and MOTS-C is not an FDA-approved drug.
Treatment is considered only following an individualized medical evaluation. Your provider will review your medical history, current medications, treatment goals, potential risks, and available treatment options before determining whether treatment is clinically appropriate.




Reviews
There are no reviews yet.